[144] Veris Residential, Inc. SEC Filing

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) filing a Form 144 notifies the proposed sale of 85,440 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,373,003.71. The shares represent part of an outstanding base of 93,421,769 shares and are slated for sale on or about 09/11/2025 on the NYSE. The filing shows the 85,440 shares were acquired in three open market purchases in 2018 (05/21, 07/18, 07/23) and paid in cash. The document also discloses multiple sales by affiliated entities during 09/09–09/10/2025 totaling 300,000 shares with gross proceeds noted for each transaction. The filer certifies no undisclosed material adverse information and includes standard Rule 144 representations.

Positive

• Full Rule 144 disclosure with broker, acquisition dates, payment method, and proposed sale date provided
• Acquisitions funded in cash in 2018 (05/21, 07/18, 07/23) indicating clear provenance of the shares

Negative

• Recent affiliated sales totaling 300,000 shares occurred on 09/09–09/10/2025, increasing share supply in the market
• Proposed sale of 85,440 shares by an affiliate or insider may represent further downward pressure if clustered with other sales

Insights

Securities Analyst

TL;DR Routine Rule 144 notice for proposed sale of 85,440 shares, consistent with prior open-market acquisitions and recent affiliated sales.

The Form 144 outlines a planned disposition of 85,440 common shares valued at $1,373,003.71, to be executed through Morgan Stanley Smith Barney on the NYSE on 09/11/2025. The shares were acquired in 2018 via open-market purchases and paid in cash, which supports a straightforward transfer under Rule 144. The filing also discloses affiliated entity sales of 300,000 shares across 09/09–09/10/2025 with recorded gross proceeds. From a market-impact perspective, this is a disclosure of insider/affiliate selling activity rather than operational or financial data about Veris Residential itself.

Compliance/Risk Analyst

TL;DR Disclosure meets Rule 144 requirements; contains explicit acquisition, sale and broker details and the required certification about material information.

The filing provides the necessary Rule 144 information: acquisition dates and amounts, nature of acquisition (open market), payment method (cash), broker identification, proposed sale date, and aggregate market value. It includes the signature representation that no undisclosed material adverse information exists. The presence of multiple affiliated sales totaling 300,000 shares in the prior two days is notable for monitoring potential concentration or secondary-market supply but is presented as transaction data without explanatory context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	85440	1373003.71	93421769	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/23/2018	Open Market Purchase	Open Market			33632	07/25/2018	Cash
Common	05/21/2018	Open Market Purchase	Open Market			48889	05/23/2018	Cash
Common	07/18/2018	Open Market Purchase	Open Market			2919	07/20/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Veris Residential's (VRE) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 85,440 common shares valued at $1,373,003.71, to be executed on or about 09/11/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

When and how were the 85,440 shares being offered acquired?

The 85,440 shares were acquired in three open-market purchases in 2018 (05/21 for 48,889 shares, 07/18 for 2,919 shares, and 07/23 for 33,632 shares) and were paid for in cash.

Did the filing report any recent sales of Veris Residential shares by related parties?

Yes; the filing lists sales by related entities on 09/09–09/10/2025 totaling 300,000 shares with gross proceeds reported for each transaction.

Who is the broker handling the proposed sale in the Form 144?

The broker named in the filing is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filer assert there is undisclosed material information about Veris Residential?

The filer represents by signature that they do not know of any material adverse information